Literature DB >> 11716779

Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domain.

D Borgel1, P Gaussem, C Garbay, C Bachelot-Loza, T Kaabache, W Q Liu, B Brohard-Bohn, B Le Bonniec, M Aiach, S Gandrille.   

Abstract

In the vitamin K-dependent protein family, only protein S (PS) contains a thrombin-sensitive region (TSR), located between the domain containing the gamma-carboxyglutamic acid and the first epidermal growth factor-like domain. To better define the role of TSR in the PS molecule, we expressed a recombinant human PS (rHPS) and its analogue lacking TSR (rTSR-less), and prepared factor Xa- and thrombin-cleaved rHPS. A peptide reproducing TSR (TSR-peptide) was also synthesized in an attempt to obtain direct evidence of the domain involvement in PS anticoagulant activity. In a coagulation assay, both rTSR-less and factor Xa-cleaved PS were devoid of activated protein C cofactor activity. The TSR-peptide did not inhibit rHPS activity, showing that TSR must be embedded in the native protein to promote interaction with activated protein C. The binding of rHPS to activated platelets and to phospholipid vesicles was not modified after factor Xa- or thrombin-mediated TSR cleavage, whereas the binding of rTSR-less was markedly reduced. This suggested a role for TSR in conferring to PS a strong affinity for phospholipid membranes. TSR-peptide did not directly bind to activated platelets or compete with rHPS for phospholipid binding. The results of the present study show that TSR may not interact directly with membranes, but probably constrains the gamma-carboxyglutamic acid-rich domain in a conformation allowing optimal interaction with phospholipids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716779      PMCID: PMC1222251          DOI: 10.1042/0264-6021:3600499

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Use of the Hmb backbone-protecting group in the synthesis of difficult sequences.

Authors:  R G Simmonds
Journal:  Int J Pept Protein Res       Date:  1996 Jan-Feb

2.  Role of Fc gamma RIIA gene polymorphism in human platelet activation by monoclonal antibodies.

Authors:  C Bachelot; R Saffroy; S Gandrille; M Aiach; F Rendu
Journal:  Thromb Haemost       Date:  1995-12       Impact factor: 5.249

3.  The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S.

Authors:  M van Wijnen; J G Stam; C van't Veer; J C Meijers; P H Reitsma; R M Bertina; B N Bouma
Journal:  Thromb Haemost       Date:  1996-09       Impact factor: 5.249

4.  Calcium-dependent interaction between gamma-carboxyglutamic acid-containing and N-terminal epidermal growth factor-like modules in factor X.

Authors:  C Valcarce; A Holmgren; J Stenflo
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

5.  Expression and functional characterization of chimeras between human and bovine vitamin-K-dependent protein-S-defining modules important for the species specificity of the activated protein C cofactor activity.

Authors:  X He; L Shen; B Dahlbäck
Journal:  Eur J Biochem       Date:  1995-01-15

6.  The relative orientation of Gla and EGF domains in coagulation factor X is altered by Ca2+ binding to the first EGF domain. A combined NMR-small angle X-ray scattering study.

Authors:  M Sunnerhagen; G A Olah; J Stenflo; S Forsén; T Drakenberg; J Trewhella
Journal:  Biochemistry       Date:  1996-09-10       Impact factor: 3.162

7.  Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.

Authors:  G A Nicolaes; G Tans; M C Thomassen; H C Hemker; I Pabinger; K Varadi; H P Schwarz; J Rosing
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

8.  Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.

Authors:  T M Hackeng; C van 't Veer; J C Meijers; B N Bouma
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

9.  Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.

Authors:  S J Koppelman; T M Hackeng; J J Sixma; B N Bouma
Journal:  Blood       Date:  1995-08-01       Impact factor: 22.113

10.  Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.

Authors:  J Rosing; L Hoekema; G A Nicolaes; M C Thomassen; H C Hemker; K Varadi; H P Schwarz; G Tans
Journal:  J Biol Chem       Date:  1995-11-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.